Merck & Co., Inc. is 140.9x more valuable than HUTCHMED (China) Ltd by market capitalization ($293.16 B vs $2.08 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | HCM | MRK |
|---|---|---|
| Market cap | $2.08 B | $293.16 B |
| US-listed rank | #2073 | #44 |
| Revenue (latest FY) | $548.51M | $65.01B |
| Net income (latest FY) | $456.91M | $18.25B |
| Net margin | 83.3% | 28.1% |
| P/E (trailing FY) | 4.6 | 16.1 |
| SEC filings | 589 | 996 |
Merck & Co., Inc. is 140.9x more valuable than HUTCHMED (China) Ltd by market capitalization ($293.16 B vs $2.08 B).
In their latest fiscal years, HUTCHMED (China) Ltd reported $548.51M in revenue while Merck & Co., Inc. reported $65.01B.
Full pages: HUTCHMED (China) Ltd and Merck & Co., Inc., or browse the full rankings.